For Better Allergy Treatment, Find Better Tests
Peanuts, shellfish, milk and soy: some people cant have a taste of these items without having severe allergic reactions. But its unknown why many patients react the way they do and how severe their reaction can be.
During National Food Allergy Awareness Week, UC volunteer assistant professor of clinical otolaryngology Steve Sutton, MD, says theres still much to learn about food allergies and why they affect some people more than others.
Though food allergy testing can carry the risk of false positives, and should be interpreted by an allergist, research has demonstrated an overall increase in the prevalence of food allergies in recent decades. Self-reported survey data in the U.S. suggests an 18 percent increase in food or digestive allergies from 1997 to 2007. Other surveys found notable increases in pediatric allergies to tree nuts and peanut allergies.
With this increase, Sutton says the field needs testing that can determine the exact nature of a patients allergy.
"Our most available testing, a skin test or blood test, isnt able to tell patients whether they have a life-threatening reaction or a mild reaction to the food, he says. "Only exposure can tell you that, but that can be dangerous when not done in the right setting.
To test with exposure, Sutton recommends an "oral challenge, in which patients, supervised by a trained physician, are given increasing amounts of a suspected allergen until they have a reaction or tolerate a normal serving.
"Youd be surprised at the number of people you expect to pass the challenge and dontor vice versa, he says.
That unknown factor in food allergies is what Sutton believes should be the focus of future research into allergies and immunology.
"Our biggest issue is the need to have some sort of testing or biomarker that would track, not only what the individual is truly allergic to, but to what extent, he says.
He says there are now blood tests for peanut and a few other allergens that can identify what protein leads to the individuals allergic reaction. These tests may be useful in predicting whether a patient is allergic to a protein that tracks with a more severe type of reaction or whether the patient is allergic to a protein that is less problematic. However, more research is necessary to understand how to make full use of these newer studies.
"As food allergies become more prevalent, patients are rightly insisting on adequate safety, better testing and research results that lead toward curing this problem or at least making it less burdensome, says Sutton.
Until those goals are met, Sutton is working with the patient community to advance awareness. On April 28, he served as honorary medical chair of the Food Allergy & Anaphylaxis Networks Walk for Food Allergy in Cincinnati, held at the Theodore M. Berry International Friendship Park.
The groups fundraising goal for the event was $25,000it raised more than $54,000.
"We have a long way to go, Sutton adds, "but we will get the answers we want because of the drive of the food allergy community.
Steve Sutton, MD, with a FAAN walk participant
Tags
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.